These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tolerance to isosorbide dinitrate: rate of development and reversal. Parker JO, Fung HL, Ruggirello D, Stone JA. Circulation; 1983 Nov; 68(5):1074-80. PubMed ID: 6616789 [Abstract] [Full Text] [Related]
4. Effects of disease, route of administration, cigarette smoking, food intake on the pharmacokinetics and circulatory effects of isosorbide dinitrate. Fung HL, Ruggirello D, Stone JA, Parker JO. Z Kardiol; 1983 Nov; 72 Suppl 3():5-10. PubMed ID: 6666234 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion. Santoni Y, Iliadis A, Cano JP, Luccioni R, Frances Y. J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630 [Abstract] [Full Text] [Related]
14. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs]. Kogi K, Tanaka O, Kimura T, Saito T. Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395 [Abstract] [Full Text] [Related]
17. More rapid relief of pain with isosorbide dinitrate oral spray than with sublingual tablets in elderly patients with angina pectoris. Reisin LH, Landau E, Darawshi A. Am J Cardiol; 1988 Mar 25; 61(9):2E-3E. PubMed ID: 3348136 [Abstract] [Full Text] [Related]